Immunological mechanisms of anti-inflammatory action of modified yellow clay in the experiment

Abstract

BACKGROUND: Modern scientific search and reasonable introduction of new balneofactors into sanatorium-resort recreational technologies are conditioned by the results of fundamental research. Experimental balneology is faced with the tasks of investigating poorly studied natural sources that are potentially capable of having therapeutic and preventive properties.

AIM: is to evaluate immunological mechanisms of anti-inflammatory action of external balneological medicine based on natural clays to study their therapeutic effectiveness in diseases of musculoskeletal system of degenerative-dystrophic nature.

MATERIAL AND METHODS: An experimental study was conducted with the participation of 79 laboratory animals (male rats, Wistar line) distributed by simple sampling into 5 groups: in the control group 1 (n=15) there were healthy animals (intact); in the 2nd group (n=13) the animals had adjuvant arthritis (AA) without exposure; the 3rd group (n=17) had an adjuvant arthritis model and Tambukan dirt; in the 4th group (n=17) there was model adjuvant arthritis and a course of yellow clay, the 5th group (n=17) had model adjuvant arthritis and a course of modified clay. The anti-inflammatory effects of native and modified external balneological medicine were examined by evaluating the response of immune-competent cells of peripheral blood in reproducing chronic inflammation in adjuvant arthritis model.

RESULTS: The conducted studies have shown that the external use of modified yellow clay in the form of balneological medicine Glinofir is comparable to the effect of Tambukan dirt. According to the immune marker analysis there was a significant change in population lymphocyte structure in peripheral blood as a result of adjuvant arthritis modeling, namely, the number of B-lymphocytes increased (2.5 times; p <0.02) with simultaneous reduction of total T-lymphocytes (2.5 times; p <0.05); the level of circulating immune complexes showed a tendency to increase with the animals of the group with adjuvant arthritis model without treatment (59.8±4.18 units in adjuvant arthritis and 52.4±3.44 units with healthy animals; p=0.1).

CONCLUSION: According to the results of the experimental studies, Glinofir which has immune-modulatory and anti-inflammatory effects can be recommended for subsequent introduction into clinical practice as the treatment and medical rehabilitation of patients with diseases of musculoskeletal system of degenerative-dystrophic nature.

Keywords

modified yellow clay / male rats / adjuvant arthritis / experiment

References

[1] Kulikov VY. Sanogenetic mechanisms of pelotherapy. Novosibirsk: Novosibirsk State Medical University; 1999. 210 р. (In Russ).

[2] Куликов В.Ю. Саногенетические механизмы пелоидотерапии. Новосибирск: НГМУ, 1999. 210 с.

[3] Leshchinsky AF, Zuza ZI. Peloid and pharmacotherapy in inflammatory diseases. Kyiv: Zdorov'’ya; 1985. 184 р. (In Russ).

[4] Лещинский А.Ф., Зуза З.И. Пелоидо- и фармакотерапия при воспалительных заболеваниях. Киев: Здоровь’я. 1985. 184 с.

[5] Popov SV, Mihajlov VP. Acute period of adjuvant arthritis: features of the development of inflammation and changes in the rheological properties of blood. Reg Circulat Microcircul. 2007;6(2):53–57. (In Russ).

[6] Попов С.В., Михайлов В.П. Острый период адъювантного артрита: особенности развития воспаления и изменение реологических свойств крови // Регионарное кровообращение и микроциркуляция. 2007. Т. 6, № 2. С. 53–57.

[7] Sizova LV. Influence of various methods of treatment on indicators of quality of life in patients with osteoarthritis [dissertation abstract]. Orenburg; 2004. 23 р. (In Russ).

[8] Сизова Л.В. Влияние различных методов лечения на показатели качества жизни больных остеоартрозом: Автореф. дис. … канд. мед. наук. Оренбург, 2004. 23 с.

[9] Kurbanov VA, Kajsinova AS, Demeshko NI, et al. Influence of a preformed preparation from yellow clay in comparison with the therapeutic mud of the Tambukan lake on the course of adjuvant arthritis. Resort Med. 2014;(4):31–36. (In Russ).

[10] Курбанов В.А., Кайсинова А.С., Демешко Н.И., и др. Влияние преформированного препарата из жёлтой глины в сравнении с лечебной грязью озера Тамбукан на течение адъювантного артрита // Курортная медицина. 2014. № 4. С. 31–36.

[11] Nejmark EB, Eroshchev-Shak VA, Chizhikova NP, Kompanceva EI. Interaction of clay minerals with microorganisms: review of experimental data. J General Biology. 2009;70(2):155–167. (In Russ).

[12] Неймарк Е.Б., Ерощев-Шак В.А., Чижикова Н.П., Компанцева Е.И. Взаимодействие глинистых минералов с микроорганизмами: обзор экспериментальных данных // Журнал общей биологии. 2009. Т. 70, № 2. С. 155–167.

[13] Selected lectures on clinical rheumatology. Ed. by V.A. Nasonova, N.V. Bunchuk. Moscow: Medicine; 2001. 272 р. (In Russ).

[14] Избранные лекции по клинической ревматологии / под ред. В.А. Насоновой, Н.В. Бунчука. Москва: Медицина, 2001. 272 с.

[15] Potanin AY. Early rheumatoid arthritis: clinical and immunological characteristics in various variants of the disease [dissertation abstract]. Moscow; 2006. 21 р. (In Russ).

[16] Потанин А.Ю. Ранний ревматоидный артрит: клинико-иммунологическая характеристика при различных вариантах заболевания: Автореф. дис. …канд. мед. наук. Москва, 2006. 21 с.

[17] Zhang X, Mao Z, Yu S. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J Orthop Res. 2004;22(4):742–792.

[18] Zhang X., Mao Z., Yu С. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10 // J Orthop Res. 2004. Vol. 22, N 4. P. 742–792.

[19] Abramcova AV, Demeshko NI, Reps VF, et al. The effect of modified clay and natural therapeutic mud on the state of the blood oxygen transport system in experimental arthritis. Resort Med. 2013;(2):66–71. (In Russ).

[20] Абрамцова А.В., Демешко Н.И., Репс В.Ф., и др. Влияние модифицированной глины и природной лечебной грязи на состояние кислородтранспортной системы крови при экспериментальном артрите // Курортная медицина. 2013. № 2. С. 66–71.

[21] Kurbanov VA, Mal'chukovskij LB, Danilov SR, et al. Physical and chemical composition of steel-gray clay from the Novo-Pyatigorsk quarry of the foothill region of the Stavropol Territory and the preformed balneological agent "Glinofir" obtained from it. Resort Med. 2012;(2):19–26. (In Russ).

[22] Курбанов В.А., Мальчуковский Л.Б., Данилов С.Р., и др. Физико-химический состав стально-серой глины из Ново-Пятигорского карьера предгорного района Ставропольского края и полученного из нее преформированного бальнеологического средства Глинофир // Курортная медицина. 2012. № 2. С. 19–26.

[23] Patent RUS RU 2540396 C2. Malchukovsky LB, Malchukovsky OL, Malchukovsky IL, et al. Balneological agent Glinophyte for the treatment and prevention of various diseases. (In Russ). Available from: https://yandex.ru/patents/doc/RU2540396C2_20150210. Accessed: 12.02.2022.

[24] Патент РФ на изобретение RU 2540396 C2. Мальчуковский Л.Б., Мальчуковский О.Л., Мальчуковский И.Л., и др. Бальнеологическое средство Глинофир для лечения и профилактики различных заболеваний. Режим доступа: https://yandex.ru/patents/doc/RU2540396C2_20150210. Дата обращения: 12.02.2022.

[25] Sanatorium-and-spa treatment: national guidelines. Ed. by A.N. Razumova, V.I. Starodubova, G.N. Ponomarenko. Moscow: GEOTAR-Media; 2021. 752 р. (In Russ).

[26] Санаторно-курортное лечение: национальное руководство / под ред. А.Н. Разумова, В.И. Стародубова, Г.Н. Пономаренко. Москва: ГЭОТАР-Медиа, 2021. 752 с.

[27] Physical and rehabilitation medicine: a national guide. Ed. by G.N. Ponomarenko. Moscow: GEOTAR-Media; 2020. 688 р.

[28] Физическая и реабилитационная медицина: национальное руководство / под ред. Г.Н. Пономаренко. Москва: ГЭОТАР-Медиа, 2020. 688 с.

[29] Khaidukov SV, Zurochka AV, Chereshnev VA. Cytometric analysis in clinical immunology: Monograph. Ekaterinburg; 2011. 221 р. (In Russ).

[30] Хайдуков С.В., Зурочка А.В., Черешнев В.А. Цитометрический анализ в клинической иммунологии: Монография. Екатеринбург, 2011. 221 с.

[31] Gashchkova V, Matl I, Kashlik I, Kogandrle V. Circulating Ag-At complexes in patients with immunocomplex diseases. Czechoslovak Medicine. 1978;(2):117–120. (In Russ).

[32] Гащкова В., Матл И., Кашлик И., Когандрле В. Циркулирующие комплексы Ag-At у больных с иммунокомплексными заболеваниями // Чехословацкая медицина. 1978. № 2. С. 117–120.

RIGHTS & PERMISSIONS

Eco-Vector